RICHARD F WALLMAN Insider Trading $CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RICHARD F WALLMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RICHARD F WALLMAN. RICHARD F WALLMAN is Director in ROPER TECHNOLOGIES INC ($ROP) and Director in CONVERGYS CORP ($CVG) and Director in CHARLES RIVER LABORATORIES INTERNATIONAL INC ($CRL) and Director in Wright Medical Group N.V. ($TRNX) and in Extended Stay America, Inc. ($STAY) and Director in Extended Stay America, Inc. ($STAY) and Director in SmileDirectClub, Inc. ($SDC).
RICHARD F WALLMAN in CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Trading Symbol: CRLIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of RICHARD F WALLMAN: Director
Holdings: 32,070 shares
Current Value: $2,648,341
Latest Transaction: May 10 2021
$CRL Market Capitalization: $3.90B
$CRL Previous Close: $82.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RICHARD F WALLMAN in CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CRL, CVG, STAY, ROP, SDC, TRNX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 10 2021 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Option Exercise | A | 342.55 | 1,151 | 394,275 | 1,151 | |
May 10 2021 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 219 | 0 | 32,289 | 32.1 K to 32.3 K (+0.68 %) |
May 10 2021 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 355 | 0 | 32,070 | 31.7 K to 32.1 K (+1.12 %) |
Nov 03 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Buy | P | 233.24 | 6,050 | 1,411,104 | 6,050 | 0 to 6.1 K |
Nov 03 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Buy | P | 232.96 | 1,150 | 267,902 | 31,715 | 30.6 K to 31.7 K (+3.76 %) |
May 12 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Option Exercise | A | 164.24 | 2,539 | 417,005 | 2,539 | |
May 12 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 457 | 0 | 30,565 | 30.1 K to 30.6 K (+1.52 %) |
May 12 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 741 | 0 | 30,108 | 29.4 K to 30.1 K (+2.52 %) |
Feb 14 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Option Exercise | M | 52.29 | 3,530 | 184,584 | 0 | |
Feb 14 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Sell | S | 174.29 | 3,530 | 615,258 | 29,367 | 32.9 K to 29.4 K (-10.73 %) |
Feb 14 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Buy | M | 52.29 | 3,530 | 184,584 | 32,897 | 29.4 K to 32.9 K (+12.02 %) |
Feb 14 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Option Exercise | M | 70.29 | 3,140 | 220,711 | 0 | |
Feb 14 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Option Exercise | M | 43.39 | 4,030 | 174,862 | 0 | |
Feb 14 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Sell | S | 172.02 | 7,170 | 1,233,391 | 29,367 | 36.5 K to 29.4 K (-19.62 %) |
Feb 14 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Buy | M | 70.29 | 3,140 | 220,711 | 36,537 | 33.4 K to 36.5 K (+9.40 %) |
Feb 14 2020 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Buy | M | 43.39 | 4,030 | 174,862 | 33,397 | 29.4 K to 33.4 K (+13.72 %) |
May 23 2019 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 580 | 0 | 29,367 | 28.8 K to 29.4 K (+2.01 %) |
May 23 2019 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 1,882 | 0 | 28,787 | 26.9 K to 28.8 K (+6.99 %) |
May 15 2018 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 676 | 0 | 26,928 | 26.3 K to 26.9 K (+2.58 %) |
May 15 2018 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 2,004 | 0 | 26,252 | 24.2 K to 26.3 K (+8.26 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 822 | 0 | 24,248 | 23.4 K to 24.2 K (+3.51 %) |
May 15 2017 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 2,436 | 0 | 23,426 | 21 K to 23.4 K (+11.61 %) |
Dec 14 2016 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Option Exercise | M | 33.93 | 4,540 | 154,042 | 0 | |
Dec 14 2016 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Buy | M | 33.93 | 4,540 | 154,042 | 20,990 | 16.5 K to 21 K (+27.60 %) |
Aug 01 2016 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Option Exercise | M | 40.27 | 7,740 | 311,690 | 0 | |
Aug 01 2016 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Sell | S | 88.00 | 7,740 | 681,120 | 16,450 | 24.2 K to 16.5 K (-32.00 %) |
Aug 01 2016 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Buy | M | 40.27 | 7,740 | 311,690 | 24,190 | 16.5 K to 24.2 K (+47.05 %) |
May 16 2016 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Sell | S | 82.50 | 470 | 38,775 | 16,450 | 16.9 K to 16.5 K (-2.78 %) |
May 16 2016 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Sell | S | 82.41 | 200 | 16,482 | 16,920 | 17.1 K to 16.9 K (-1.17 %) |
May 16 2016 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Sell | S | 82.31 | 800 | 65,848 | 17,120 | 17.9 K to 17.1 K (-4.46 %) |
May 16 2016 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Sell | S | 82.15 | 500 | 41,075 | 17,920 | 18.4 K to 17.9 K (-2.71 %) |
May 16 2016 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 730 | 0 | 18,420 | 17.7 K to 18.4 K (+4.13 %) |
May 16 2016 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 2,260 | 0 | 17,690 | 15.4 K to 17.7 K (+14.65 %) |
May 12 2016 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Option Exercise | M | 37.81 | 11,990 | 453,342 | 0 | |
May 12 2016 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Sell | S | 84.00 | 11,990 | 1,007,160 | 15,430 | 27.4 K to 15.4 K (-43.73 %) |
May 12 2016 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Buy | M | 37.81 | 11,990 | 453,342 | 27,420 | 15.4 K to 27.4 K (+77.71 %) |
May 09 2016 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Sell | S | 81.00 | 2,720 | 220,320 | 15,430 | 18.2 K to 15.4 K (-14.99 %) |
May 07 2015 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Option Exercise | A | 70.29 | 3,140 | 220,711 | 3,140 | |
May 07 2015 | CRL | CHARLES RIVER LABO ... | WALLMAN RICHARD F | Director | Grant | A | 0.00 | 1,970 | 0 | 18,150 | 16.2 K to 18.2 K (+12.18 %) |
Page: 1